United States - English - NLM (National Library of Medicine)

tommie copper, inc. - trolamine salicylate (unii: h8o4040bhd) (salicylic acid - unii:o414pz4lpz) - topical analgesic. adults and children 12 years of age : apply generously to the affected area, massage into painful area until thoroughly absorbed into the skin, repeat as necessary, but not more than 3 to 4 times daily. children under 12 years of age : ask a doctor.

United States - English - NLM (National Library of Medicine)

acutens, inc. - triethanolamine salicylate 10% - topical analgesic temporarily relieves mild aches and pains of muscles and joints. do not use around eye area, on open wounds, cuts, damaged or infected skin, mouth genitals or any other mucous membrance. if contact occurs, flush thoroughly with water. if irritation develops, discontinue use.

United States - English - NLM (National Library of Medicine)

ani pharmaceuticals, inc. - hydroxychloroquine sulfate (unii: 8q2869cnvh) (hydroxychloroquine - unii:4qwg6n8qkh) - hydroxychloroquine sulfate tablets is indicated in adult and pediatric patients for the: - treatment of uncomplicated malaria due to plasmodium falciparum, plasmodium malariae, plasmodium vivax, and plasmodium ovale. - prophylaxis of malaria in geographic areas where chloroquine resistance is not reported. limitations of use: hydroxychloroquine sulfate tablets is not recommended for: - treatment of complicated malaria. - treatment of malaria by chloroquine or hydroxychloroquine-resistant strains of plasmodium species [see microbiology (12.4)]. - treatment of malaria acquired in geographic areas where chloroquine resistance occurs or when the plasmodium species has not been identified. - prophylaxis of malaria in geographic areas where chloroquine resistance occurs. - prevention of relapses of p. vivax or p. ovale because it is not active against the hypnozoite liver stage forms of these parasites. for radical cure of p. vivax and p. ovale infections, concomitant therapy with an 8-aminoquinoline drug i

United States - English - NLM (National Library of Medicine)

merz north america, inc. - titanium dioxide 12.25% zinc oxide 10.2% - sunscreen - helps prevent sunburn and premature skin aging. - if used as directed with other sun protection measures (see directions ), decreases the risk of skin cancer and early skin aging caused by the sun. - higher spf gives more sunburn protection.

United States - English - NLM (National Library of Medicine)

ani pharmaceuticals, inc. - dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - allergic states control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, and serum sickness. dermatologic diseases bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, and severe erythema multiforme (stevens-johnson syndrome). endocrine disorders primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; may be used in conjunction with synthetic mineralocorticoid analogs where applicable; in infancy mineralocorticoid supplementation is of particular importance), congenital adrenal hyperplasia, hypercalcemia associated with cancer, and nonsuppurative thyroiditis. gastrointestinal diseases to tide the patient over a critical period of the disease in regional enteritis and ulcerative colitis. hematologic disorders acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia (diamond-blackfan anemia), idiopathic thrombocytopenic purpura in adults, pure red cell aplasia, and selected cases of secondary thrombocytopenia. miscellaneous diagnostic testing of adrenocortical hyperfunction, trichinosis with neurologic or myocardial involvement, tuberculous meningitis with subarachnoid block or impending block when used with appropriate antituberculous chemotherapy. neoplastic diseases for the palliative management of leukemias and lymphomas. nervous system acute exacerbations of multiple sclerosis, cerebral edema associated with primary or metastatic brain tumor, craniotomy, or head injury. ophthalmic diseases sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids. renal diseases to induce a diuresis or remission of proteinuria in idiopathic nephrotic syndrome or that due to lupus erythematosus. respiratory diseases berylliosis, fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy, idiopathic eosinophilic pneumonias, symptomatic sarcoidosis. rheumatic disorders as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis, acute rheumatic carditis, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low- dose maintenance therapy). for the treatment of dermatomyositis, polymyositis, and systemic lupus erythematosus. systemic fungal infections (see warnings, fungal infections). dexamethasone tablets are contraindicated in patients who are hypersensitive to any components of this product.

United States - English - NLM (National Library of Medicine)

cvs - trolamine salicylate (unii: h8o4040bhd) (salicylic acid - unii:o414pz4lpz) - topical analgesic temporarily relieves minor pain associated with: arthritis simple backache muscle strains sprains bruises

United States - English - NLM (National Library of Medicine)

aace pharmaceuticals, inc. - butalbital (unii: khs0az4jvk) (butalbital - unii:khs0az4jvk), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - butalbital and acetaminophen tablets are indicated for the relief of the symptom complex of tension (or muscle contraction) headache. evidence supporting the efficacy and safety of this combination product in the treatment of multiple recurrent headaches is unavailable. caution in this regard is required because butalbital is habit-forming and potentially abusable. this product is contraindicated under the following conditions: - hypersensitivity or intolerance to any component of this product. - patients with porphyria. abuse and dependence: butalbital: barbiturates may be habit-forming: tolerance, psychological dependence, and physical dependence may occur especially following prolonged use of high doses of barbiturates. the average daily dose for the barbiturate addict is usually about 1500 mg. as tolerance to barbiturates develops, the amount needed to maintain the same level of intoxication increases; tolerance to a fatal dosage, however, does not increase more than two-fold. as this occur

Malta - English - Medicines Authority

g. r. lane health products limited sisson road, gloucester, gl2 0gr, united kingdom - camphor, hamamelis virginiana, eucalyptus oil, zinc oxide, methyl salicylate, melaleuca oil - cream - camphor 0.52 % (w/w) hamamelis virginiana 40.61 % (w/w) eucalyptus oil 1.04 % (w/w) zinc oxide 3.11 % (w/w) methyl salicylate 1.04 % (w/w) melaleuca oil 2.5 % (w/w) - antiseptics and disinfectants

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - trolamine salicylate 10%{relative} (as 11.1%w/wtriethanolamine salicylate 90%); trolamine salicylate 10%{relative} (as 11.1%w/wtriethanolamine salicylate 90%) - topical cream - 10% w/w - active: trolamine salicylate 10%{relative} (as 11.1%w/wtriethanolamine salicylate 90%) excipient: cetostearyl alcohol glycerol glyceryl monostearate hard paraffin imidurea laneth-5 and ceteth 5 and oleath 5 and steareth 5 light liquid paraffin methyl hydroxybenzoate phenoxyethanol propyl hydroxybenzoate propylene glycol purified water sodium laurilsulfate stearic acid trolamine yellow soft paraffin active: trolamine salicylate 10%{relative} (as 11.1%w/wtriethanolamine salicylate 90%) excipient: cetomacrogol 1000 cetostearyl alcohol glycerol glyceryl monostearate isopropyl myristate lanolin light liquid paraffin methyl hydroxybenzoate phenoxyethanol propyl hydroxybenzoate propylene glycol purified water stearic acid trolamine

United States - English - NLM (National Library of Medicine)

mckesson corporation dba sky packaging - furosemide (unii: 7lxu5n7zo5) (furosemide - unii:7lxu5n7zo5) - furosemide 20 mg - furosemide tablets, usp is indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. furosemide is particularly useful when an agent with greater diuretic potential is desired. furosemide tablets, usp may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents. hypertensive patients who cannot be adequately controlled with thiazides will probably also not be adequately controlled with furosemide alone. furosemide tablets are contraindicated in patients with anuria and in patients with a history of hypersensitivity to furosemide.